Candida antigen extract patch VDMN-21

{
  "id": "MLC-T-ONC-012222",
  "term": "Candida antigen extract patch VDMN-21",
  "field": "Oncology and biomedicine",
  "definition": "An dissolvable microarray-based formulation containing an extract of Candida albicans (C. albicans) antigens, with immunomodulatory activity. Upon administration of the C. albicans antigen extract patch VDMN-21 adjacent to the cutaneous human papilloma virus (HPV)-infected wart(s), the C. albicans antigens, upon release from the microarray, stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL)-mediated immune response against the C. albicans antigens and cause a delayed type hypersensitivity response against other local antigens, including antigens within the wart tissue. This leads to the production of Th1 cytokines, and the activation of natural killer (NK) cell- and CTL- mediated killing of HPV-infected cells. This causes clearing of both local and distant warts, and prevents HPV infection and wart formation that results from HPV infection.",
  "synonyms": [
    "Candida antigen extract-containing microneedle patch VDMN-21",
    "C. albicans antigen extract patch VDMN-21"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/candida-antigen-extract-patch-vdmn-21/"
}